“The current scenario has exposed some structural weaknesses during the EU’s medicines provide chain in addition to a large dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides stated. She proposed that provide chain concerns be resolved in an EU pharmaceutical system predicted being introduced by th… Read More